Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Irene Aires"'
Autor:
Noemí Puig, Cristina Agulló, Teresa Contreras, José-Juan Pérez, Irene Aires, María-José Calasanz, Ramón García-Sanz, Sergio Castro, Joaquín Martínez-López, Paula Rodríguez-Otero, Verónica González-Calle, Marta S González, Albert Oriol, Norma C Gutiérrez, Rafael Ríos-Tamayo, Laura Rosiñol, Miguel-Ángel Álvarez, Joan Bargay, Ana-Pilar González-Rodríguez, Adrián Alegre, Fernando Escalante, María-Belén Iñigo, Javier de la Rubia, Ana-Isabel Teruel, Felipe de Arriba, Luis Palomera, Miguel T Hernández, Javier López-Jiménez, Marta Reinoso, Aránzazu García-Mateo, Enrique M Ocio, Joan Bladé, Juan-José Lahuerta, María-Teresa Cedena, Bruno Paiva, Jesús F San Miguel, María-Victoria Mateos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data are yet available in high-risk smoldering myeloma (HRsMM). We have therefore
Externí odkaz:
https://doaj.org/article/c81a444b8f6e434cb89c96b45ea2aec6
Autor:
María García-Álvarez, Ana Yeguas, Cristina Jiménez, Alejandro Medina-Herrera, Verónica González-Calle, Montserrat Hernández-Ruano, Rebeca Maldonado, Irene Aires, Cristina Casquero, Inmaculada Sánchez-Villares, Ana Balanzategui, María Eugenia Sarasquete, Miguel Alcoceba, María Belén Vidriales, Marcos González-Díaz, Ramón García-Sanz, María Carmen Chillón
Publikováno v:
Biomedicines, Vol 12, Iss 1, p 66 (2023)
Single-cell DNA sequencing can address the sequence of somatic genetic events during myeloid transformation in relapsed acute myeloid leukemia (AML). We present an NPM1-mutated AML patient with an initial low ratio of FLT3-ITD (low-risk ELN-2017), tr
Externí odkaz:
https://doaj.org/article/c7362ffa7647486f8f5d47e173974eb5
Autor:
Tamara Jimenez-Solas, Beatriz Albarrán, Rebeca Ortega, Félix López-Cadenas, Luis García-Martín, Fermín Sánchez-Guijo, José María Quiroga Alonso, Angel Hernández-Hernández, Consuelo del Cañizo, Irene Aires-Mejia, Alba Redondo, María Díez-Campelo, Juan Carlos Caballero-Berrocal, Sandra Muntión
Publikováno v:
British journal of haematologyREFERENCES. 187(1)
Patients with low-risk myelodysplastic syndromes (MDS) usually develop iron overload. This leads to a high level of oxidative stress in the bone marrow (BM) and increases haematopoietic cell dysfunction. Our objective was to analyse whether chelation
Autor:
Leire Burgos, Sarvide Sarai, Alberto Orfao, Noemi Puig, Joaquin Martinez-Lopez, Erika Lorenzo-Vivas, Ibai Goicoechea, Andreas Agathangelidis, Joan Bladé, Jose A. Martinez-Climent, Sara Rodriguez, Jesús F. San-Miguel, Ramón García-Sanz, Maria-Victoria Mateos, Juan José Garcés, Idoia Rodriguez, Rafael Valdés-Mas, Katerina Gemenetzi, Anastasia Hadzidimitriou, Laura Rosinol Dachs, Irene Aires, Diego Alignani, Amaia Vilas-Zornoza, María Teresa Cedena, Felipe Prosper, Bruno Paiva, Juan José Lahuerta, José J. Pérez, Cirino Botta, María José Calasanz
Publikováno v:
Blood. 134:509-509
In MM patients relapsing after MRD-negativity, the disease could reemerge from immature cells or from undetectable MRD. However, it remains unknown if immature cells have the same genetic background as MM plasma cells (PCs), as well as the amount of
Autor:
M A Alvarez, Noemi Puig, Norma C. Gutiérrez, Javier Lopez, Marta González, Adrian Alegre, Aránzazu García Mateo, Rafael Martínez, Joan Bladé, Fernando Escalante, Veronica Gonzalez De La Calle, Jesús F. San-Miguel, Javier de la Rubia, Ana Isabel Teruel, Luis Palomera, José J. Pérez, Cristina Agullo, Joaquin Martinez-Lopez, Ramón García-Sanz, Felipe de Arriba, María Teresa Cedena, Irene Aires, Teresa Contreras, Paula Rodriguez Otero, Maria-Victoria Mateos, Ana Pilar Gonzalez, Joan Bargay, Rafael Rios, Bruno Paiva, Enrique M. Ocio, María José Calasanz, Juan José Lahuerta, Miguel-Teodoro Hernández, Laura Rosiñol, Albert Oriol, Jesús Martín
Publikováno v:
Blood. 134:581-581
Introduction: The GEM-CESAR trial is a potentially curative strategy for high-risk smoldering multiple myeloma (HRsMM) patients in which the primary endpoint is the assessment of bone marrow minimal residual disease negativity by next generation flow
Autor:
J. Bargay, Mercedes Garayoa, J de la Rubia, V. González de la Calle, A. Díaz-Tejedor, N. Puig, Maria-Teresa Cedena, R. García-Sanz, M.V. Mateos, J F San Miguel, A. Oriol, Teresa Contreras, Milagros Hernández, J.J. Lahuerta, N. C. Gutierrez, F de Arriba, Irene Aires-Mejia, Teresa Paíno, F. Escalante, Laura Rosiñol, E. Rodero, Bruno Paiva, A. García Mateo, J. Bladé, E.M. Ocio, R. Pessoa, J.J. Pérez
Publikováno v:
HemaSphere. 3:617-618
Autor:
Josefina Galende, Paloma Bárcena, Diego Alignani, Alfonso García de Coca, Maria-Luz Sanchez, Noemi Puig, Rebeca Cuello, Alberto Orfao, Maria-Victoria Mateos, Luis A. Corchete, María-Belén Vidriales, José L. Alonso, Abelardo Bárez, Bruno Paiva, Cristina Jimenez, Irene Aires-Mejia, Maria-Carmen Montes, Norma C. Gutiérrez, Ramón García-Sanz, Tomás José González-López, José Augusto Evangelho Hernandez, M. E. Sarasquete, Jesús F. San Miguel, Enrique M. Ocio, Fernando Escalante, Magdalena Sierra, José de Jesús Pérez, Emilia Pardal
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Although information about the molecular pathogenesis of Waldenström macroglobulinemia (WM) has significantly advanced, the precise cell of origin and the mechanisms behind WM transformation from immunoglobulin-M (IgM) monoclonal gammopathy of undet
Autor:
Ana-Isabel Teruel, J.J. Pérez, V. González de la Calle, Laura Rosiñol, R. Rios, Milagros Hernández, N. Puig, J. Martínez-López, J. Lopez, Irene Aires, J F San Miguel, A Alegre, M.V. Mateos, Teresa Contreras, J de la Rubia, Cristina Agullo, F de Arriba, Luis Palomera, A. Oriol, Paula Rodriguez-Otero, M.-A. Alvarez, Bruno Paiva, Maria-Teresa Cedena, A. García Mateo, J. Bladé, J. Bargay, Marta González, J.J. Lahuerta, F. Escalante, J. Martín, R. Martínez, E.M. Ocio, A.-P. González, N. C. Gutierrez, Maria-Jose Calasanz
Publikováno v:
HemaSphere. 3:258
Autor:
J M Sayagués, Luis A. Corchete, Ramón García-Sanz, Montserrat Martín, Mercedes Garayoa, Maria-Victoria Mateos, Laura San-Segundo, Jesús F. San Miguel, Teresa Paíno, Enrique M. Ocio, Paloma Bárcena, Bruno Paiva, Alberto Orfao, María-Belén Vidriales, Norma C. Gutiérrez, Irene Aires-Mejia, Maria-Luz Sanchez, Ines Mota, Cristina Jimenez
Publikováno v:
Blood. 122:3591-3598
Circulating myeloma tumor cells (CTCs) as defined by the presence of peripheral blood (PB) clonal plasma cells (PCs) are a powerful prognostic marker in multiple myeloma (MM). However, the biological features of CTCs and their pathophysiological role
Autor:
M B Vidriales, Teresa Paíno, J M Sayagués, Jesús F. San-Miguel, María Eugenia Sarasquete, J.J. Lahuerta, Ramón García-Sanz, M.V. Mateos, Luis A. Corchete, Miguel-Teodoro Hernández, Laura San-Segundo, Albert Oriol, Tiago Carvalheiro, Jessica Pérez, María-Asunción Echeveste, Ines Mota, Norma C. Gutiérrez, Bruno Paiva, A. Orfao, Maria-Luz Sanchez, Artur Paiva, J. Bladé, Irene Aires-Mejia, Paloma Bárcena, Enrique M. Ocio
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Knowledge about clonal diversity and selection is critical to understand multiple myeloma (MM) pathogenesis, chemoresistance and progression. If targeted therapy becomes reality, identification and monitoring of intraclonal plasma cell (PC) heterogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be628f3a17dcfa811761064f4fd27765
http://hdl.handle.net/10261/135727
http://hdl.handle.net/10261/135727